Point-of-care (POC)

As we enter the winter flu season, embracing more innovative diagnostics at the point of care (POC) could play a vital role in helping to address the burden which influenza places on public health services. Read more


A clinical trial has been started to evaluate and validate a urine-based point of care (POC) diagnostic from Mologic, aimed at helping cystic fibrosis (CF) patients monitor and manage their condition at home. Read more


Mologic (developer of personalised diagnostics) has signed agreements with two medical companies — Medisur and Peripal — for the distribution of a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD) Read more


The ultra-rapid Point-Of-Care (POC) molecular diagnostics company, Atlas Genetics, has received a £2 million phase II contract from Innovate UK for the expansion of the STI test menu on its io rapid diagnostic platform. Read more